Laughter Is Essential When Living with a Chronic Illness By Stacie Prada Sometimes feeling crummy and being overwhelmed makes a person forget to do things that didn’t take any thought when they felt well. ...
Relapsing-remitting MS: Alemtuzumab boosts outcomes for black patientsA trial reveals that the drug alemtuzumab may improve outcomes for black patients with relapsing-remitting multiple sclerosis, who are often understudied. … read morePosted At: Medical News...
Researchers from Italy Report that Skin Tissue May Hold Promise for Treating Multiple Sclerosis/About-the-Society/News/Researchers-from-Italy-Report-that-Skin-Tissue-May … read morePosted At: National MS Society
Veto on Home Modifications Bill in Maine Unanimously Overridden/About-the-Society/News/Veto-on-Home-Modifications-Bill-in-Maine-Unanimous … read morePosted At: National MS Society
Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodiesMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Canbex Therapeutics Raises $ 3.2 million to Develop Treatment for Debilitating Muscle Spasms Associa
Canbex Therapeutics Raises $ 3.2 million to Develop Treatment for Debilitating Muscle Spasms Associa/About-the-Society/News/Canbex-Therapeutics-Raises-$-3-2-million-to-Develo … read morePosted At: National MS Society
Join Our Mailing List
- Updates From ECTRIMS Research Conference
- Environmental factors may trigger onset of multiple sclerosisPosted At: Science Daily
- Genetic Ancestry Associated with Clinical Course in Hispanic-Latinos: Study is Ongoing
- Prognostic information for people with MS: Impossible or inevitable?
- New immunotherapy targeting blood-clotting proteinPosted At: Science Daily
- Animal models of multiple sclerosis: From rodents to zebrafish
- Inclusion criteria used in trials of people with progressive multiple sclerosis
- Do cannabinoids ease multiple sclerosis symptoms?Posted At: Medical News Today
- Results Reported from Innovative “MS-SMART” Clinical Trial in Secondary Progressive MS Presented at
- Hidden cost of pembrolizumab therapy